// COMPANY
Actio Biosciences
SECTOR BIOTECHMENTIONS 1LAST SEEN AUGUST 11, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
m_and_a·Axios Pro Rata·AUGUST 11, 2026
“Actio Biosciences, a San Diego-based biotech focused on neurological disorders, acquired by Jazz Pharmaceuticals for $820M upfront + up to $500M in earnouts.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.